NRX Pharmaceuticals, Inc. (NRXP) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $7.80M | +440.3% |
| 2024 | $1.44M | -68.6% |
| 2023 | $4.59M | -77.1% |
| 2022 | $20.05M | -27.4% |
| 2021 | $27.61M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $7.80M | +440.3% |
| 2024 | $1.44M | -68.6% |
| 2023 | $4.59M | -77.1% |
| 2022 | $20.05M | -27.4% |
| 2021 | $27.61M | — |